Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
121G is a private investment, advisory, and technology development company that builds, incubates, and supports software-driven businesses, with a notable emphasis on healthcare technology. The company develops and markets proprietary platforms including 10Bridge, a cloud-native healthcare data interoperability and AI-based data refinery platform, and HealthCoach, an AI-enabled training and quality assurance platform for chronic care management organizations. Beyond product incubation, 121G provides software development, cloud, interoperability, analytics, and consulting services to external companies and portfolio businesses. Its public materials position the company as a hands-on strategic investor and operator rather than a traditional therapeutics developer. Overall, 121G appears best characterized as a healthcare-focused technology and company-building platform with commercial software products rather than a biotech or pharma drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 121G.